Corominas, Jordi
Klein, Marieke http://orcid.org/0000-0001-8784-5679
Zayats, Tetyana
Rivero, Olga http://orcid.org/0000-0002-2664-4053
Ziegler, Georg C.
Pauper, Marc
Neveling, Kornelia
Poelmans, Geert
Jansch, Charline
Svirin, Evgeniy
Geissler, Julia
Weber, Heike http://orcid.org/0000-0002-9421-1292
Reif, Andreas http://orcid.org/0000-0002-0992-634X
Arias Vasquez, Alejandro
Galesloot, Tessel E.
Kiemeney, Lambertus A. L. M.
Buitelaar, Jan K.
Ramos-Quiroga, Josep-Antoni
Cormand, Bru
Ribasés, Marta http://orcid.org/0000-0003-1039-1116
Hveem, Kristian
Gabrielsen, Maiken Elvestad
Hoffmann, Per
Cichon, Sven
Haavik, Jan
Johansson, Stefan
Jacob, Christian P.
Romanos, Marcel
Franke, Barbara http://orcid.org/0000-0003-4375-6572
Lesch, Klaus-Peter
Article History
Received: 8 June 2017
Revised: 1 May 2018
Accepted: 18 June 2018
First Online: 16 August 2018
Compliance with ethical standards
:
: BF received educational speaking fees from Merz and Shire. KPL served as a speaker for Eli Lilly and received research support from Medice, as did AR, all outside the submitted work. JH received speaker fees from Eli Lilly, HB Pharma, and Shire. In the past 3 years, JKB has been a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Medice, Novartis, and Servier. He has received research support from Roche and Vifor. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. All other authors report no biomedical financial interests or potential conflicts of interest.